Global Med Technologies(R), Inc. Licenses EdgeLab to Seven Laboratories at University Hospital of Reims, France
October 15 2009 - 9:00AM
PR Newswire (US)
French Subsidiary of Global Med Technologies(R), Inc., INLOG, S.A.,
Chosen by Large University Hospital for Total Replacement of Aging
LIS DENVER, Oct. 15 /PRNewswire-FirstCall/ -- Global Med
Technologies®, Inc. ("Global Med" or the "Company") (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international healthcare information
technology company, today announced that its Inlog subsidiary has
licensed its EdgeLab Laboratory Information Management Software
(marketed as "Labo Serveur" in France) to the seven laboratories at
University Hospital of Reims. Financial terms of this substantial
agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) The
Reims' laboratories handle a full range of clinical laboratory
functions with their daily workload exceeding 700 patient files per
day. EdgeLab will be deployed on over 170 workstations and will be
directly connected to over 40 laboratory analyzers. According to
Mrs. Cornu, the IT representative for the University Hospital of
Reims, the reasons behind the hospital's choice were based on
different factors: a technical architecture that corresponded to
their desires, a more intuitive and user-friendly product than what
the competition offered and a very broad functional basis that
covered all of the requirements of the relevant wards. In addition,
the on-site demonstrations and especially the visit to the
University Hospital of Besancon were also very persuasive. Since
EdgeLab was introduced into the hospital market in 1999 as "Labo
Serveur", it has become a leading laboratory information management
system in Europe with more than 150 licensed laboratories. EdgeLab
is connected to more than 1,000 analyzers and interchanges data
with all major hospital healthcare software applications. It has a
vibrant, easy-to-use Windows graphical interface in addition to a
comprehensive range of laboratory functionality. EdgeLab can be
easily configured to meet the business needs of large, diverse,
multi-site hospital laboratories, as well as small, single-site
hospitals. Will Willman, Global Med's Senior Vice President of
Sales and Marketing EU/ME/Asia, commented, "We are very proud to
have been selected by the University Hospital of Reims to assist
their seven laboratories with our laboratory information management
system. EdgeLab has proven capabilities for the complex
requirements of multi-site university hospitals with multiple
laboratories. We are looking forward to supporting University
Hospital of Reims with quality products and services as they
continue to provide excellent, advanced healthcare to patients in
the greater Reims area." About the University Hospital of Reims The
University Hospital of Reims, France, has almost 2,500 beds
throughout its nine facilities. It handles 20,000 surgical
procedures and 1,700 births each year at its pediatric facility.
Its emergency service manages 67,000 cases per year. About Global
Med Technologies®, Inc. Global Med Technologies, Inc. is an
international healthcare information technology company which
develops regulated and non-regulated products and services for the
healthcare industry. As a leading provider of blood and laboratory
systems and services, Global Med's products are deployed in 20
countries and serve over 2,100 transfusion centers, blood banks and
laboratory sites. Global Med's domestic companies are Wyndgate
Technologies®, a leader in software products and services for donor
centers and hospital transfusion services; eDonor®, which offers
web-based donor relationship management systems; and PeopleMed(TM),
Inc., which implements cost-effective software validation,
consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer
of donor center and transfusion management systems as well as
cellular therapy software, laboratory information systems and
quality assurance medical software systems internationally. For
more information about Global Med's products and services, please
call 800-996-3428 or visit http://www.globalmedtech.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies,
Inc., +1-303-238-2000; or, investors, Jeffrey Benison,
+1-212-334-8709, , for Global Med Technologies, Inc. Web Site:
http://www.globalmedtech.com/
Copyright